Mankind Pharma Ltd (NSE:MANKIND) (Q2 2027) Earnings Call Highlights: Revenue Jumps 17% as EBITDA Margins Expand to 27.1%
· gurufocus.com
Revenue: INR4,338 crores in Q2 FY27, up 17.3% YoY from INR3,697 crores in Q2 FY26.Domestic Revenue (ex-Consumer Healthcare): INR3,428 crores, up 15.9% YoY.Domes
Revenue: INR4,338 crores in Q2 FY27, up 17.3% YoY from INR3,697 crores in Q2 FY26.
INR4,338 crores in Q2 FY27, up 17.3% YoY from INR3,697 crores in Q2 FY26. Do...